KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationCost of RevenueDepreciation & Amortization (IS)EBIATLeasesMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Receivables - NetShares Repurchased
Ratios

GoodRx Holdings (GDRX) Shares Repurchased (2022 - 2025)

GoodRx Holdings' Shares Repurchased history spans 4 years, with the latest figure at $9.4 million for Q4 2025.

  • For Q4 2025, Shares Repurchased rose 4915.96% year-over-year to $9.4 million; the TTM value through Dec 2025 reached $216.4 million, up 36.22%, while the annual FY2025 figure was $216.4 million, 36.22% up from the prior year.
  • Shares Repurchased for Q4 2025 was $9.4 million at GoodRx Holdings, down from $61.1 million in the prior quarter.
  • Across five years, Shares Repurchased topped out at $153.2 million in Q1 2024 and bottomed at $188000.0 in Q4 2024.
  • The 4-year median for Shares Repurchased is $18.0 million (2022), against an average of $44.7 million.
  • The largest annual shift saw Shares Repurchased plummeted 99.76% in 2024 before it skyrocketed 4915.96% in 2025.
  • A 4-year view of Shares Repurchased shows it stood at $18.0 million in 2022, then surged by 333.42% to $77.8 million in 2023, then tumbled by 99.76% to $188000.0 in 2024, then surged by 4915.96% to $9.4 million in 2025.
  • Per Business Quant, the three most recent readings for GDRX's Shares Repurchased are $9.4 million (Q4 2025), $61.1 million (Q3 2025), and $61.0 million (Q2 2025).